← FDA DRUG APPROVALS

FDA ANDA · ANDA086742

CHOLEDYL SA

Sponsor: WARNER CHILCOTT LLC

APPLICATION
ANDA086742
TYPE
ANDA
ORIGINAL APPROVAL
1981-11-05
LATEST ACTION
1999-06-08
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

CHOLEDYL SADiscontinued
OXTRIPHYLLINE 600MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1999-06-08Manufacturing (CMC) · Supplement 19AP
1999-06-08Manufacturing (CMC) · Supplement 18AP
1999-06-08Labeling · Supplement 20AP
1998-02-24Manufacturing (CMC) · Supplement 16AP
1993-07-19Labeling · Supplement 13AP
1992-08-12Manufacturing (CMC) · Supplement 12AP
1991-10-18Labeling · Supplement 3AP
1991-08-21Manufacturing (CMC) · Supplement 9AP
1990-11-06Bioequivalence · Supplement 10AP
1988-10-13Bioequivalence · Supplement 7AP
1984-01-10Manufacturing (CMC) · Supplement 6AP
1984-01-10Manufacturing (CMC) · Supplement 4AP
1984-01-10Manufacturing (CMC) · Supplement 2AP
1981-11-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →